UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000008272
Receipt number R000009699
Scientific Title Safety and Efficacy of Carbone Dioxide Angiography for endovascular therapy in patients with chronic kidney disease: Prospective multicenter observational study
Date of disclosure of the study information 2012/06/28
Last modified on 2013/06/14 23:17:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Safety and Efficacy of Carbone Dioxide Angiography for endovascular therapy in patients with chronic kidney disease: Prospective multicenter observational study

Acronym

CO2 angiography registry

Scientific Title

Safety and Efficacy of Carbone Dioxide Angiography for endovascular therapy in patients with chronic kidney disease: Prospective multicenter observational study

Scientific Title:Acronym

CO2 angiography registry

Region

Japan


Condition

Condition

Patients with chronic kidney disease (eGFR<60 mL/min/1.73m2) and symptomatic renal artery stenosis and/or symptomatic peripheral arterial disease ( Rutherford Classification Category 2-5)

Classification by specialty

Cardiology Vascular surgery Radiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We evaluate safety and efficacy of CO2 angiography and reduced contrast media assisted endovascular therapy for chronic kidney disease.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Worsening of renal function (serum Cr, eGFR)

Key secondary outcomes

1) Procedural success
2) Complications of procedure
3) Major adverse event (death, Myocardial infarction, end stage of renal dysfunction (renal death, renal replacement therapy),stroke, reintervenshon thrapy
4) Contrast induced nephropathy


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with chronic kidney disease (eGFR<60 mL/min/1.73m2) and symptomatic renal artery stenosis and/or symptomatic peripheral arterial disease ( Rutherford Classification Category 2-5)

Key exclusion criteria

Patients on Hemodialysis
Patients with solitary below the knee artery disease

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Daizo Kawasaki

Organization

Hyogo Collage of Medicine

Division name

Cardiovascular Division

Zip code


Address

1-1 Mukogawa-cho, Nishinomiya City,Hyogo,Japan

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name Masahiko Fujihara

Organization

Kishiwada Tokushukai Hospital

Division name

Cardiovascular Division

Zip code


Address

4-27-1 Kamori-cho Kisiwada-City,Osaka,Japan

TEL

072-445-9915

Homepage URL


Email

masahiko-fujihara@themis.ocn.ne.jp


Sponsor or person

Institute

Kishiwada Tokushukai Hospital
Hyogo Collage of Medicine

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

Shin-Koga Hospital
Tokeidai Memorial Hospital
Miyazak Medical Association Hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

天神会 新古賀病院
カレスサッポロ 時計台記念病院
宮崎市郡医師会病院


Other administrative information

Date of disclosure of the study information

2012 Year 06 Month 28 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 06 Month 21 Day

Date of IRB


Anticipated trial start date

2012 Year 07 Month 01 Day

Last follow-up date

2013 Year 06 Month 01 Day

Date of closure to data entry

2013 Year 06 Month 01 Day

Date trial data considered complete

2013 Year 06 Month 01 Day

Date analysis concluded

2013 Year 08 Month 01 Day


Other

Other related information

pre procedure,post procedure within 5days,1month later,3month later


Management information

Registered date

2012 Year 06 Month 26 Day

Last modified on

2013 Year 06 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009699


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name